FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Choosing the right credit card for travel rewards can be challenging. Find out which options provide the best benefits for you.
27,921 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Nvidia sits at a potential turning point, guided by a history of cycles tied to AI and data centers. This article unf...
Chewy just popped. stock momentum followed a better-than-expected 2026 outlook, even as Q4 growth stayed modest. This...
Pi Network reports rising KYC completion and robust Mainnet migration, as upgrades lay groundwork for smart contracts...
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
As e.l.f. Beauty moves into 2026, investors want clarity on growth drivers and risk. This guide breaks down the Q4 ou...
Strategy shifted roughly 411 BTC to Coinbase Prime, prompting a fresh look at its cash strategy. The move has revived...
SpaceX is the talk of Wall Street, but a rush to buy at the IPO could be reckless. This guide explains why waiting fo...
Tesla’s AI ambitions are under the microscope as spending climbs and milestones approach. This report analyzes what i...
Franklin Templeton filed for two DRIP-focused ETFs that would redirect dividend payouts from U.S. stocks into Bitcoin...
FEPI’s high yield relies on aggressive call-writing against a tech-heavy basket. While payouts appear robust, scrutin...
Two popular clean-energy ETFs shape many investors' portfolios. This guide breaks down iShares Global Clean Energy an...